Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.91% |
| 2 | Technology | 4.35% |
| 3 | Healthcare | 4.25% |
| 4 | Industrials | 4.06% |
| 5 | Consumer Discretionary | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WDR
951
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $34.2M | 0.02% |
1,614,928
+1,107,255
| +218% | +$22.3M |
|
952
CALL
Thermo Fisher Scientific
TMO
$223B
| $34.2M | 0.02% |
140,000
+66,900
| +92% | +$15.4M |
|
953
Check Point Software Technologies
CHKP
$13.2B
| $34.1M | 0.02% |
289,717
+255,704
| +752% | +$29.1M |
|
954
Nutanix
NTNX
$17.5B
| $34.1M | 0.02% |
797,642
+427,572
| +116% | +$22.6M |
|
955
Labcorp
LH
$26.2B
| $34.1M | 0.02% |
228,355
+224,489
| +5,807% | +$34.1M |
|
956
PUT
Newmont
NEM
$120B
| $34M | 0.02% |
1,126,700
+179,300
| +19% | +$6.07M |
|
957
Global Payments
GPN
$25.1B
| $34M | 0.02% |
266,771
+210,019
| +370% | +$25.3M |
|
958
CALL
MetLife
MET
$61.4B
| $34M | 0.02% |
727,300
+131,400
| +22% | +$6M |
|
959
Chemours
CC
$2.29B
| $34M | 0.02% |
861,518
+714,592
| +486% | +$31.3M |
|
960
CALL
Mondelez International
MDLZ
$79.4B
| $33.9M | 0.02% |
789,400
+91,100
| +13% | +$3.89M |
|
961
PUT
Dropbox
DBX
$7.31B
| $33.9M | 0.02% |
1,263,000
+254,200
| +25% | +$7.34M |
|
962
Howmet Aerospace
HWM
$112B
| $33.9M | 0.02% |
2,006,975
-364,211
| -15% | -$5.8M |
|
963
CALL
Carnival Corporation Ltd
CCL
$38.9B
| $33.8M | 0.02% |
530,400
+279,300
| +111% | +$16.9M |
|
|
WW
964
DELISTED
WW International
WW
| $33.7M | 0.02% |
468,601
+236,502
| +102% | +$19.2M |
|
965
PUT
eBay
EBAY
$45.5B
| $33.7M | 0.02% |
1,021,300
-275,200
| -21% | -$9.54M |
|
966
Healthpeak Properties
DOC
$14.2B
| $33.6M | 0.02% |
1,276,642
-2,273,281
| -64% | -$59.8M |
|
967
Nomad Foods
NOMD
$1.68B
| $33.6M | 0.02% |
1,658,017
-297,142
| -15% | -$5.88M |
|
968
Ares Management
ARES
$32.1B
| $33.5M | 0.02% |
+1,445,494
| New | +$31M |
|
969
PUT
Sarepta Therapeutics
SRPT
$1.94B
| $33.5M | 0.01% |
207,400
-5,900
| -3% | -$807K |
|
970
Fortis
FTS
$28.7B
| $33.5M | 0.01% |
1,033,460
+978,184
| +1,770% | +$31.8M |
|
971
Nokia
NOK
$59B
| $33.5M | 0.01% |
5,995,962
+3,413,221
| +132% | +$19M |
|
|
TIF
972
CALL
DELISTED
Tiffany & Co.
TIF
| $33.3M | 0.01% |
258,100
+95,600
| +59% | +$12.5M |
|
|
PDCE
973
DELISTED
PDC Energy, Inc.
PDCE
| $33.3M | 0.01% |
679,698
-1,087,351
| -62% | -$60.3M |
|
974
CALL
iShares US Home Construction ETF
ITB
$2.37B
| $33.3M | 0.01% |
941,600
+645,700
| +218% | +$24.5M |
|
975
PUT
General Dynamics
GD
$107B
| $33.2M | 0.01% |
162,200
-67,100
| -29% | -$13.1M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.